Topical Rapamycin to Erase Angiofibromas in TSC (Treatment)
This study is currently recruiting participants.
Verified January 2013 by The University of Texas Health Science Center, Houston
Sponsor:
The University of Texas Health Science Center, Houston
Information provided by (Responsible Party):
Mary Kay Koenig, The University of Texas Health Science Center, Houston
ClinicalTrials.gov Identifier:
NCT01526356
First received: February 1, 2012
Last updated: January 28, 2013
Last verified: January 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | August 2013 |
| Estimated Primary Completion Date: | August 2013 (Final data collection date for primary outcome measure) |